Insightec

Jump to navigation Jump to search

WikiDoc Resources for Insightec

Articles

Most recent articles on Insightec

Most cited articles on Insightec

Review articles on Insightec

Articles on Insightec in N Eng J Med, Lancet, BMJ

Media

Powerpoint slides on Insightec

Images of Insightec

Photos of Insightec

Podcasts & MP3s on Insightec

Videos on Insightec

Evidence Based Medicine

Cochrane Collaboration on Insightec

Bandolier on Insightec

TRIP on Insightec

Clinical Trials

Ongoing Trials on Insightec at Clinical Trials.gov

Trial results on Insightec

Clinical Trials on Insightec at Google

Guidelines / Policies / Govt

US National Guidelines Clearinghouse on Insightec

NICE Guidance on Insightec

NHS PRODIGY Guidance

FDA on Insightec

CDC on Insightec

Books

Books on Insightec

News

Insightec in the news

Be alerted to news on Insightec

News trends on Insightec

Commentary

Blogs on Insightec

Definitions

Definitions of Insightec

Patient Resources / Community

Patient resources on Insightec

Discussion groups on Insightec

Patient Handouts on Insightec

Directions to Hospitals Treating Insightec

Risk calculators and risk factors for Insightec

Healthcare Provider Resources

Symptoms of Insightec

Causes & Risk Factors for Insightec

Diagnostic studies for Insightec

Treatment of Insightec

Continuing Medical Education (CME)

CME Programs on Insightec

International

Insightec en Espanol

Insightec en Francais

Business

Insightec in the Marketplace

Patents on Insightec

Experimental / Informatics

List of terms related to Insightec


InSightec Ltd., founded in 1999, is a privately held company owned by Elbit Medical Imaging (EMI), General Electric, private investors and employees. InSightec was founded specifically to develop MR (magnetic resonance) guided Focused Ultrasound technology. Headquartered in Tirat Hacarmel near Haifa, Israel, with US headquarters in Dallas Texas, the company has over 100 employees.

InSightec developed ExAblate® 2000 – a surgical system that combines Magnetic resonance imaging and Focused Ultrasound to non-invasively treat tumors inside the body without the need for incisions. During this outpatient procedure, the patient lies inside an MRI scanner, which provides three-dimensional images of the diseased tissue and surrounding area, enabling precise guidance of the ultrasound waves. High intensity focused ultrasound waves are then directed into the body at specific tissue, raising the temperature of the targeted tissue to 65 to 85 degrees Celsius, destroying it. The imaging capabilities of the MRI scanner provide real-time feedback on all aspects of the procedure which gives the physician a high degree of control over its therapeutic outcome.

ExAblate® 2000 has been approved to treat uterine fibroids, and is currently in use in the US, Israel, Europe and Asia. Clinical trials are being conducted to evaluate ExAblate® 2000 for treatment of other diseases such as breast, liver, bone and brain cancers.


See also

External links



Template:WikiDoc Sources